Rigel Pharmaceuticals
RIGL
#7467
Rank
A$0.50 B
Marketcap
$28.51
Share price
-2.35%
Change (1 day)
45.21%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): A$40.25 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are A$0.17 Billion. , an increase over its 2023 earnings that were of -A$30.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 A$43.47 M-244.27%
2023 -A$30.14 Million-66.79%
2022 -A$90.75 Million340.73%
2021 -A$20.6 Million-56.15%
2020 -A$46.96 Million-57.34%
2019 -A$0.12 Billion-7.66%
2018 -A$0.12 Billion-9.47%
2017 -A$0.14 Billion24.46%
2016 -A$0.11 Billion23.63%
2015 -A$85.59 Million-43.29%
2014 -A$0.16 Billion2.5%
2013 -A$0.15 Billion
2010 A$62.61 M-133.97%
2009 -A$0.19 Billion-18.49%
2008 -A$0.23 Billion71.91%
2007 -A$0.14 Billion84.74%
2006 -A$71.2 Million-10.17%
2005 -A$79.27 Million-15.73%
2004 -A$94.06 Million39.29%
2003 -A$67.53 Million10.3%
2002 -A$61.23 Million48.3%
2001 -A$41.29 Million-2.13%
2000 -A$42.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-596.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.17 Billion-474.55%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.25 B 39,593.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$7.62 B 17,435.38%๐Ÿ‡บ๐Ÿ‡ธ USA